Skip to main content

Warberg Asset Management LLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1597506 WINNETKA, IL

Position in ESPR

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
2 quarters on record

Derivatives in ESPR

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$0
PutShares
374,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

All Filings in ESPR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 374,000
2023-09-30 13,000